Abstract:The cytokines of transforming growth factor beta (TGF-beta) and its superfamily members are potent regulators of tumorigenesis and multiple cellular events. Myostatin is a member of TGF-beta superfamily and plays a negative role in the control of cell proliferation and differentiation. We now show that myostatin rapidly activated the extracellular signal-regulated kinase 1/2 (Erk1/2) cascade in C2C12 myoblasts. A more remarkable Erk1/2 activation stimulated by myostatin was observed in differentiating cells than proliferating cells. The results also showed that Ras was the upstream regulator and participated in myostatin-induced Erk1/2 activation because the expression of a dominant-negative Ras prevented myostatin-mediated inhibition of Erk1/2 activation and proliferation. Importantly, the myostatin-suppressed myotube fusion and differentiation marker gene expression were attenuated by blockade of Erk1/2 mitogen-activated protein kinase (MAPK) pathway through pretreatment with MAPK/Erk kinase 1 (MEK1) inhibitor PD98059, indicating that myostatin-stimulated activation of ErkI/2 negatively regulates myogenic differentiation. Activin receptor type IIb (ActRIIb) was previously suggested as the only type II membrane receptor triggering myostatin signaling. In this study, by using synthesized small interfering RNAs and dominant-negative ActRIIb, we show that myostatin failed to stimulate Erk1/2 phosphorylation and could not inhibit myoblast differentiation in ActRIIb-knockdown C2C12 cells, indicating that ActRIIb was required for myostatin-stimulated differentiation suppression. Altogether, our findings in this report provide the first evidence to reveal functional role of the Erk1/2 MAPK pathway in myostatin action as a negative regulator of muscle cell growth.

Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism

Promoting Bone Morphogenetic Protein Signaling Through Negative Regulation of Inhibitory Smads

Regulation of TGF-β Superfamily Signaling by Inhibitory Smads

Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling

Extracellular Signal–Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway is Involved in Myostatin-Regulated Differentiation Repression

Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

Post-translational regulation of TGF-β receptor and Smad signaling.

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Induction of Inhibitory Smad6 and Smad7 Mrna by Tgf-Beta Family Members

Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7

Regulation of Myostatin on the Growth and Development of Skeletal Muscle

Identification of gene expression modifications in myostatin-stimulated myoblasts.

Posttranslational Regulation of Smads

Negative Regulation of TGF-β Receptor/smad Signal Transduction

Smad7 Antagonizes Transforming Growth Factor Β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

Smad7: Not Only a Regulator, but Also a Cross-Talk Mediator of TGF-β Signalling

Smad6 Promotes Neuronal Differentiation In The Intermediate Zone Of The Dorsal Neural Tube By Inhibition Of The Wnt/Beta-Catenin Pathway

Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.

Myostatin Regulates Mir-431 Expression Via the Ras-Mek-Erk Signaling Pathway

Regulation of TGF- signaling by Smad7

Smad6 Recruits Transcription Corepressor CtBP to Repress Bone Morphogenetic Protein-Induced Transcription.